Washington, D.C.
Federal regulators this week rejected a request to sell a morning-after birth-control pill without a prescription. The drug, Plan B, can prevent ovulation or keep a fertilized egg from implanting if taken within 72 hours of sex. The Food and Drug Administration said drug maker Barr Pharmaceuticals had failed to prove girls could safely use Plan B without a doctor’s help. Conservative activist Wendy Wright praised the ruling, saying the drug was too potent to be sold “next to candy bars and toothpaste.” But birth-control advocate Kirsten Moore said the decision denied women “a safe, proven second chance to prevent pregnancy.”
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
-
'Time-honored political tactic: Throw your wife under the bus'Today's Newspapers A roundup of the headlines from the US front pages
-
Best non-alcoholic spirits for summer cocktailsThe Week Recommends As hard liquor takes a backseat for many, the ingredients for the perfect mocktail are dryly delicious
-
Will Biden's tariffs hinder China's EV dominance?Today's Big Question Climate change goals and American jobs in tension
